Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
Clinical trial NCT00235508 · COMPLETED
Trial details
- NCT number
- NCT00235508
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2006-04-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.